NextCure (NXTC) Invested Capital (2018 - 2021)

NextCure's Invested Capital history runs 4 years deep, the most recent figure standing at $2.6 million for Q2 2021.

• In Q2 2021, Invested Capital fell 39.53% year-over-year to $2.6 million; the TTM figure through Mar 2022 stood at $2.6 million (down 82.43% YoY), while the FY2020 annual figure was $3.5 million, down 30.0% from the prior year.
• Invested Capital for Q2 2021 stood at $2.6 million, down from $3.1 million in the prior quarter.
• The five-year high for Invested Capital was $5.0 million in Q2 2019, with the low at $278000.0 in Q1 2019.
• The 4-year median for Invested Capital is $3.9 million (2020), against an average of $3.4 million.
• The sharpest annual moves came in 2020 and 2021: Invested Capital soared 1590.65% in 2020, then tumbled 39.53% in 2021.
• NextCure's Invested Capital stood at $480000.0 in 2018, then surged by 941.67% to $5.0 million in 2019, then fell by 30.0% to $3.5 million in 2020, then retreated by 25.71% to $2.6 million in 2021.
• Business Quant data shows NXTC's Invested Capital at $2.6 million in Q2 2021, $3.1 million in Q1 2021, and $3.5 million in Q4 2020.